Skip to content

Neural Correlates of Empathogenic and Affiliative Actions of Oxytocin

Neural Correlates of the Empathogenic and Affiliative Actions of Oxytocin

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01701180
Acronym
ODIS
Enrollment
23
Registered
2012-10-04
Start date
2012-08-31
Completion date
2013-08-31
Last updated
2014-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Male Volunteers

Brief summary

Mounting evidence indicates that the intranasal administration of the neuropeptide oxytocin has prosocial effects. However, the neural substrates of these effects are still unclear. The investigators hypothesized that a single dose administration of oxytocin should increase empathogenic and affiliative responses and that these effects are mediated by an increased insula activity.

Interventions

DRUGOxytocin

24 IU; 3 puffs per nostril, each with 4 IU OXT

DRUGPlacebo

Sponsors

University Hospital, Bonn
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy male volunteers * In a heterosexual relationship

Exclusion criteria

* Current or past psychiatric disease * Current or past physical illness * Psychoactive medication * Tobacco smokers

Design outcomes

Primary

MeasureTime frameDescription
Empathy ratings and their neural correlatesAbout one hour after the intranasal administration of oxytocinAll subjects are scanned while they view emotional and neutral faces and rate their empathy for these stimuli.

Secondary

MeasureTime frameDescription
Neural correlates of pair-bondingAbout one hour after the intranasal administration of oxytocinAll subjects are scanned while they view a picture of their mate and and an unknown female.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026